Patents by Inventor Celia MENDEZ

Celia MENDEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075117
    Abstract: The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such microbiota sequence variants are useful for the preparation of anticancer medicaments, since they differ from self-antigens and, thus, they may elicit a strong immune response. Accordingly, medicaments comprising microbiota sequence variants, methods of preparing such medicaments and uses of such medicaments are provided.
    Type: Application
    Filed: June 26, 2023
    Publication date: March 7, 2024
    Inventors: Laurent CHENE, Alessandra Cervino, Francesco Strozzi, Celia Mendez, Christophe Bonny
  • Patent number: 11712465
    Abstract: The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such microbiota sequence variants are useful for the preparation of anticancer medicaments, since they differ from self-antigens and, thus, they may elicit a strong immune response. Accordingly, medicaments comprising microbiota sequence variants, methods of preparing such medicaments and uses of such medicaments are provided.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: August 1, 2023
    Assignee: ENTEROME S.A.
    Inventors: Laurent Chene, Alessandra Cervino, Francesco Strozzi, Celia Mendez, Christophe Bonny
  • Publication number: 20200256877
    Abstract: The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such microbiota sequence variants are useful for the preparation of anticancer medicaments, since they differ from self-antigens and, thus, they may elicit a strong immune response. Accordingly, medicaments comprising microbiota sequence variants, methods of preparing such medicaments and uses of such medicaments are provided.
    Type: Application
    Filed: October 9, 2018
    Publication date: August 13, 2020
    Inventors: Laurent CHENE, Francesco STROZZI, Christophe BONNY, Alessandra CERVINO, Celia MENDEZ
  • Publication number: 20200025774
    Abstract: The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such microbiota sequence variants are useful for the preparation of anticancer medicaments, since they differ from self-antigens and, thus, they may elicit a strong immune response. Accordingly, medicaments comprising microbiota sequence variants, methods of preparing such medicaments and uses of such medicaments are provided.
    Type: Application
    Filed: October 9, 2017
    Publication date: January 23, 2020
    Applicant: ENTEROME S.A.
    Inventors: Laurent CHENE, Alessandra CERVINO, Francesco STROZZI, Celia MENDEZ, Christophe BONNY